White House signs H.R. 7148 into law, tightening rules on PBMs distorting Georgia drug prices

Donald Trump, the 45th President of the United States, known for his business background and “America First” policy agenda
Donald Trump, the 45th President of the United States, known for his business background and “America First” policy agenda
0Comments

The White House announced that congressional bill H.R. 7148 has been signed into law, which includes reforms targeting pharmacy benefit manager (PBM) practices by shifting compensation away from rebate-linked incentives and expanding transparency requirements, an issue gaining attention in Georgia. 

According to AJMC, the spending law introduces Medicare Part D PBM reforms designed to reduce incentives tied to higher list prices. The policy “delinks” PBM compensation from rebates and list prices by moving PBMs toward flat administrative fees, a change supporters say can weaken “rebate maximization” and steer plans away from higher-priced drugs that generate bigger rebates.

Under the new provisions described in coverage of the law, PBMs would be required to pass through 100% of rebates, fees, and other remuneration to the payer, with Centers for Medicare & Medicaid Services (CMS) monetary penalties available for noncompliance. The goal, as reported by AJMC, is to ensure rebate dollars do not remain with middlemen and to improve accountability for how savings are handled.

PBMs sit between insurers/payers, drug manufacturers, and pharmacies—negotiating rebates and building formularies and pharmacy networks that shape what patients pay and where they can fill prescriptions. Federal scrutiny has intensified: the FTC’s interim staff report on “prescription drug middlemen” argues PBM concentration and vertical integration can disadvantage patients and independent pharmacies without sufficient transparency.

Georgia’s “Pharmacy Anti-Steering and Transparency Act” cites PBM/affiliate referral steering as a conflict of interest that can “limit or eliminate competitive alternatives,” “increase costs,” and “disproportionately harm” patients in rural and medically underserved areas—one reason the state moved to restrict steering and require more transparency.

The White House serves as the executive branch office supporting the President and communicates official administration actions through its public “Briefings & Statements” releases. These postings serve as the government’s on-the-record record for presidential actions and policy announcements, archived for public access on WhiteHouse.gov.



Related

Jon G. Burns, Georgia State Representative from 159th District

Rep. Viola Davis to recognize Sigma Gamma Rho Sorority Day at State Capitol

Rep. Viola Davis announced plans to honor Sigma Gamma Rho Sorority Day at the Georgia State Capitol on March 16. The event will celebrate the sorority’s contributions in education and public service.

Theodore S. Hertzberg United States Attorney for the Northern District of Georgia

Federal charges filed after Norcross drug busts yield fentanyl, methamphetamine, and firearms

Two men face federal charges after authorities seized large quantities of fentanyl, methamphetamine, and firearms during operations in Norcross this week. Officials say these actions reflect ongoing efforts against drug trafficking networks threatening public safety across northern Georgia.

Lisa Campbell, Georgia House Representative for District 35

Rep. Lisa Campbell announces Dr. Beverly Griffin Patton as recipient of 2026 Yellow Rose Award

State Representative Lisa Campbell named Dr. Beverly Griffin Patton as a recipient of the 2026 Yellow Rose Nikki T. Randall Servant Leader Award on March 11. The award honors women who show exceptional leadership and service in their communities.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Peach Tree Times.